Holmes, E A
Bonsall, M B
Hales, S A
Mitchell, H
Renner, F
Blackwell, S E
Watson, P
Goodwin, G M
Di Simplicio, M
Article History
Received: 21 July 2015
Revised: 9 November 2015
Accepted: 10 November 2015
First Online: 26 January 2016
Competing interests
: GMG declares shares in P1vital and in the last 2 years having served as consultant, advisor or continuing medical education speaker for AstraZeneca, Abbvie, Cephalon/Teva, Convergence, Eli Lilly and Co, GSK, Lundbeck, Medscape, Merck, Otsuka, P1vital, Servier, Sunovion and Takeda. The remaining authors declare no conflict of interest.